| A new era in pharmacovigilance: toward real‐world data and digital monitoring A Lavertu, B Vora, KM Giacomini, R Altman, S Rensi Clinical Pharmacology & Therapeutics 109 (5), 1197-1202, 2021 | 69 | 2021 |
| Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives L Zou, P Spanogiannopoulos, LM Pieper, HC Chien, W Cai, N Khuri, ... Proceedings of the National Academy of Sciences 117 (27), 16009-16018, 2020 | 47 | 2020 |
| Meta-analysis of maternal and fetal transcriptomic data elucidates the role of adaptive and innate immunity in preterm birth B Vora, A Wang, I Kosti, H Huang, I Paranjpe, TJ Woodruff, T MacKenzie, ... Frontiers in immunology 9, 993, 2018 | 44 | 2018 |
| Drug–nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3) B Vora, EAE Green, N Khuri, F Ballgren, M Sirota, KM Giacomini The American journal of clinical nutrition 111 (1), 110-121, 2020 | 36 | 2020 |
| Drugs in COVID‐19 clinical trials: predicting transporter‐mediated drug‐drug interactions using in vitro assays and real‐world data SW Yee, B Vora, T Oskotsky, L Zou, S Jakobsen, OJ Enogieru, ... Clinical Pharmacology & Therapeutics 110 (1), 108-122, 2021 | 20 | 2021 |
| Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics B Vora, DJ Brackman, L Zou, M Garcia‐Cremades, M Sirota, RM Savic, ... Clinical and translational science 14 (4), 1431-1443, 2021 | 12 | 2021 |
| Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins S Chung, YL Lin, V Nguyen, L Kamen, K Zheng, B Vora, A Song Journal of immunological methods 462, 101-105, 2018 | 11 | 2018 |
| Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval–An Industry Perspective R Zhu, B Vora, S Menon, I Younis, G Dwivedi, Z Meng, A Datta‐Mannan, ... Clinical Pharmacology & Therapeutics 114 (4), 751-767, 2023 | 9 | 2023 |
| Applications of advanced natural language processing for clinical pharmacology JC Hsu, M Wu, C Kim, B Vora, YT Lien, A Jindal, K Yoshida, S Kawakatsu, ... Clinical Pharmacology & Therapeutics 115 (4), 786-794, 2024 | 8 | 2024 |
| Nurturing diversity and inclusion in AI in Biomedicine through a virtual summer program for high school students T Oskotsky, R Bajaj, J Burchard, T Cavazos, I Chen, WT Connell, S Eaneff, ... PLoS computational biology 18 (1), e1009719, 2022 | 7 | 2022 |
| The Effect of Trimethoprim on Thiamine Absorption: A Transporter‐Mediated Drug‐Nutrient Interaction B Vora, A Wen, SW Yee, K Trinh, M Azimi, EAE Green, M Sirota, ... Clinical Pharmacology & Therapeutics 114 (2), 381-392, 2023 | 5 | 2023 |
| Inhibition of muscarinic receptor signaling protects human enteric inhibitory neurons against platin chemotherapy toxicity MN Richter, S Farahvashi, RM Samuel, H Majd, AK Chemel, JT Ramirez, ... BioRxiv, 2023.03. 08.531806, 2023 | 4 | 2023 |
| The effects of genetic mutations and drugs on the activity of the thiamine transporter, SLC19A2 OJ Enogieru, ML Koleske, B Vora, H Ngo, SW Yee, D Chatad, M Sirota, ... The AAPS Journal 23, 1-8, 2021 | 4 | 2021 |
| Clinical pharmacokinetics and brain penetration of GDC-0084, an oral PI3K/mTor inhibitor in patients with high-grade glioma KM Morrissey, B Vora, R Zhu, D Apt, AG Olivero, JA Ware, LU Mueller, ... Clin Pharmacol Ther 99, S5-S107, 2016 | 2 | 2016 |
| Expanding the use of real‐world data through the development of user‐friendly tools to support drug development: Example of an organ impairment dashboard B Vora, E Velasquez, R Zhang, K Igras, SL James, P Chanu Pharmacology Research & Perspectives 12 (4), 2024 | | 2024 |
| Applying Natural Language Processing to ClinicalTrials. gov: mRNA cancer vaccine case study B Vora, D Kuruvilla, C Kim, M Wu, CS Shemesh, GA Roth Clinical and Translational Science 16 (12), 2417-2420, 2023 | | 2023 |
| Prevalence and utility of pharmacokinetic data in preclinical studies of mRNA cancer vaccines GA Roth, B Vora, C Kim, M Wu, D Kuruvilla Clinical and Translational Science 16 (9), 1554-1558, 2023 | | 2023 |
| Establishing a stem cell model to uncover the mechanism of chemotherapy-induced enteric neuropathy MN Richter, RM Samuel, H Majd, J Wu, A Arab, B Vora, F Fattahi NEUROGASTROENTEROLOGY AND MOTILITY 33, 2021 | | 2021 |
| INTERSECTION OF PRE-CLINICAL, CLINICAL, AND REAL-WORLD DATA: A MULTI-FACETED APPROACH TO UNDERSTAND TRANSPORTER-MEDIATED DRUG-NUTRIENT INTERACTIONS. B Vora, S Yee, EE Green, M Sirota, K Giacomini CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S30-S30, 2021 | | 2021 |
| Integration of benchwork, clinical trials, and real world data to investigate drug interactions B Vora University of California, San Francisco, 2021 | | 2021 |
